GO:0006396 | RNA processing | 32.08% (17/53) | 2.89 | 0.0 | 0.0 |
GO:0090304 | nucleic acid metabolic process | 39.62% (21/53) | 2.26 | 0.0 | 0.0 |
GO:0006139 | nucleobase-containing compound metabolic process | 43.4% (23/53) | 2.1 | 0.0 | 0.0 |
GO:0016070 | RNA metabolic process | 33.96% (18/53) | 2.51 | 0.0 | 0.0 |
GO:0034470 | ncRNA processing | 22.64% (12/53) | 3.33 | 0.0 | 0.0 |
GO:1990904 | ribonucleoprotein complex | 24.53% (13/53) | 3.1 | 0.0 | 0.0 |
GO:0032991 | protein-containing complex | 45.28% (24/53) | 1.87 | 0.0 | 1e-06 |
GO:0006364 | rRNA processing | 16.98% (9/53) | 4.0 | 0.0 | 1e-06 |
GO:0016072 | rRNA metabolic process | 16.98% (9/53) | 3.86 | 0.0 | 1e-06 |
GO:0034660 | ncRNA metabolic process | 22.64% (12/53) | 3.06 | 0.0 | 2e-06 |
GO:0034641 | cellular nitrogen compound metabolic process | 45.28% (24/53) | 1.73 | 0.0 | 3e-06 |
GO:0043228 | non-membrane-bounded organelle | 35.85% (19/53) | 2.02 | 0.0 | 5e-06 |
GO:0043232 | intracellular non-membrane-bounded organelle | 35.85% (19/53) | 2.02 | 0.0 | 5e-06 |
GO:0046483 | heterocycle metabolic process | 43.4% (23/53) | 1.72 | 0.0 | 5e-06 |
GO:0005730 | nucleolus | 22.64% (12/53) | 2.7 | 0.0 | 1.8e-05 |
GO:0140513 | nuclear protein-containing complex | 22.64% (12/53) | 2.57 | 1e-06 | 4.1e-05 |
GO:0005654 | nucleoplasm | 24.53% (13/53) | 2.43 | 1e-06 | 4.3e-05 |
GO:0006725 | cellular aromatic compound metabolic process | 43.4% (23/53) | 1.52 | 1e-06 | 5.1e-05 |
GO:0030686 | 90S preribosome | 5.66% (3/53) | 7.3 | 1e-06 | 5.6e-05 |
GO:0030684 | preribosome | 9.43% (5/53) | 4.63 | 2e-06 | 0.000116 |
GO:1901360 | organic cyclic compound metabolic process | 43.4% (23/53) | 1.39 | 4e-06 | 0.000219 |
GO:0005681 | spliceosomal complex | 11.32% (6/53) | 3.82 | 4e-06 | 0.000239 |
GO:0043170 | macromolecule metabolic process | 50.94% (27/53) | 1.19 | 5e-06 | 0.000267 |
GO:0016071 | mRNA metabolic process | 16.98% (9/53) | 2.76 | 6e-06 | 0.000321 |
GO:0000469 | cleavage involved in rRNA processing | 7.55% (4/53) | 4.81 | 1.3e-05 | 0.00065 |
GO:0090501 | RNA phosphodiester bond hydrolysis | 9.43% (5/53) | 3.97 | 1.7e-05 | 0.000837 |
GO:0034476 | U5 snRNA 3'-end processing | 3.77% (2/53) | 7.94 | 2.7e-05 | 0.001203 |
GO:0071038 | nuclear polyadenylation-dependent tRNA catabolic process | 3.77% (2/53) | 7.94 | 2.7e-05 | 0.001203 |
GO:0005515 | protein binding | 66.04% (35/53) | 0.8 | 3e-05 | 0.001294 |
GO:0106354 | tRNA surveillance | 3.77% (2/53) | 7.72 | 3.8e-05 | 0.00157 |
GO:0005488 | binding | 77.36% (41/53) | 0.63 | 4.2e-05 | 0.001692 |
GO:0071042 | nuclear polyadenylation-dependent mRNA catabolic process | 3.77% (2/53) | 7.53 | 5e-05 | 0.001961 |
GO:0044238 | primary metabolic process | 58.49% (31/53) | 0.88 | 5.8e-05 | 0.002179 |
GO:0034475 | U4 snRNA 3'-end processing | 3.77% (2/53) | 7.36 | 6.5e-05 | 0.002303 |
GO:0071035 | nuclear polyadenylation-dependent rRNA catabolic process | 3.77% (2/53) | 7.36 | 6.5e-05 | 0.002303 |
GO:0016078 | tRNA catabolic process | 3.77% (2/53) | 7.2 | 8.1e-05 | 0.002721 |
GO:0071047 | polyadenylation-dependent mRNA catabolic process | 3.77% (2/53) | 7.2 | 8.1e-05 | 0.002721 |
GO:0010608 | post-transcriptional regulation of gene expression | 13.21% (7/53) | 2.64 | 0.000122 | 0.003554 |
GO:0003723 | RNA binding | 22.64% (12/53) | 1.8 | 0.000121 | 0.003589 |
GO:0000467 | exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 3.77% (2/53) | 6.94 | 0.000118 | 0.003595 |
GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' | 3.77% (2/53) | 6.94 | 0.000118 | 0.003595 |
GO:0006807 | nitrogen compound metabolic process | 52.83% (28/53) | 0.92 | 0.000114 | 0.003658 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 9.43% (5/53) | 3.4 | 0.000113 | 0.003708 |
GO:0005575 | cellular_component | 84.91% (45/53) | 0.48 | 0.000141 | 0.00383 |
GO:0000398 | mRNA splicing, via spliceosome | 7.55% (4/53) | 3.93 | 0.00014 | 0.003875 |
GO:0000459 | exonucleolytic trimming involved in rRNA processing | 3.77% (2/53) | 6.83 | 0.000139 | 0.003956 |
GO:0000176 | nuclear exosome (RNase complex) | 3.77% (2/53) | 6.72 | 0.000162 | 0.004058 |
GO:0043634 | polyadenylation-dependent ncRNA catabolic process | 3.77% (2/53) | 6.72 | 0.000162 | 0.004058 |
GO:0071029 | nuclear ncRNA surveillance | 3.77% (2/53) | 6.72 | 0.000162 | 0.004058 |
GO:0071046 | nuclear polyadenylation-dependent ncRNA catabolic process | 3.77% (2/53) | 6.72 | 0.000162 | 0.004058 |
GO:1903311 | regulation of mRNA metabolic process | 9.43% (5/53) | 3.17 | 0.000232 | 0.005693 |
GO:0043487 | regulation of RNA stability | 7.55% (4/53) | 3.71 | 0.000255 | 0.006129 |
GO:0031125 | rRNA 3'-end processing | 3.77% (2/53) | 6.36 | 0.000272 | 0.006414 |
GO:0061013 | regulation of mRNA catabolic process | 7.55% (4/53) | 3.66 | 0.000291 | 0.006735 |
GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 5.66% (3/53) | 4.54 | 0.000298 | 0.006774 |
GO:0110165 | cellular anatomical entity | 83.02% (44/53) | 0.46 | 0.000305 | 0.00681 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 7.55% (4/53) | 3.63 | 0.000315 | 0.006913 |
GO:0000375 | RNA splicing, via transesterification reactions | 7.55% (4/53) | 3.59 | 0.000347 | 0.007462 |
GO:0097525 | spliceosomal snRNP complex | 5.66% (3/53) | 4.45 | 0.000357 | 0.00756 |
GO:0034472 | snRNA 3'-end processing | 3.77% (2/53) | 6.13 | 0.000373 | 0.007756 |
GO:0030490 | maturation of SSU-rRNA | 5.66% (3/53) | 4.4 | 0.0004 | 0.008193 |
GO:0009987 | cellular process | 75.47% (40/53) | 0.53 | 0.000436 | 0.008781 |
GO:0043633 | polyadenylation-dependent RNA catabolic process | 3.77% (2/53) | 6.0 | 0.000448 | 0.008884 |
GO:0030532 | small nuclear ribonucleoprotein complex | 5.66% (3/53) | 4.32 | 0.000471 | 0.009188 |
GO:0000178 | exosome (RNase complex) | 3.77% (2/53) | 5.94 | 0.000488 | 0.009243 |
GO:1905354 | exoribonuclease complex | 3.77% (2/53) | 5.94 | 0.000488 | 0.009243 |
GO:0120114 | Sm-like protein family complex | 5.66% (3/53) | 4.28 | 0.000509 | 0.009487 |
GO:0044237 | cellular metabolic process | 56.6% (30/53) | 0.74 | 0.000574 | 0.010245 |
GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic | 3.77% (2/53) | 5.83 | 0.000574 | 0.010393 |
GO:0140142 | nucleocytoplasmic carrier activity | 3.77% (2/53) | 5.83 | 0.000574 | 0.010393 |
GO:0016075 | rRNA catabolic process | 3.77% (2/53) | 5.72 | 0.000667 | 0.011564 |
GO:0071027 | nuclear RNA surveillance | 3.77% (2/53) | 5.72 | 0.000667 | 0.011564 |
GO:0031123 | RNA 3'-end processing | 5.66% (3/53) | 4.11 | 0.000713 | 0.012197 |
GO:0003724 | RNA helicase activity | 5.66% (3/53) | 4.09 | 0.000746 | 0.012586 |
GO:0005829 | cytosol | 32.08% (17/53) | 1.17 | 0.000772 | 0.012684 |
GO:0006397 | mRNA processing | 9.43% (5/53) | 2.79 | 0.000768 | 0.012787 |
GO:0071025 | RNA surveillance | 3.77% (2/53) | 5.57 | 0.000818 | 0.012931 |
GO:0030331 | nuclear estrogen receptor binding | 3.77% (2/53) | 5.57 | 0.000818 | 0.012931 |
GO:0080008 | Cul4-RING E3 ubiquitin ligase complex | 5.66% (3/53) | 4.05 | 0.000814 | 0.013205 |
GO:0031461 | cullin-RING ubiquitin ligase complex | 7.55% (4/53) | 3.22 | 0.000898 | 0.014026 |
GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic | 3.77% (2/53) | 5.48 | 0.000927 | 0.014296 |
GO:1902494 | catalytic complex | 16.98% (9/53) | 1.8 | 0.000953 | 0.01451 |
GO:0003676 | nucleic acid binding | 32.08% (17/53) | 1.14 | 0.000972 | 0.01463 |
GO:0008186 | ATP-dependent activity, acting on RNA | 5.66% (3/53) | 3.94 | 0.001002 | 0.014903 |
GO:0060135 | maternal process involved in female pregnancy | 3.77% (2/53) | 5.32 | 0.001165 | 0.017124 |
GO:0071704 | organic substance metabolic process | 58.49% (31/53) | 0.66 | 0.001194 | 0.017146 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 5.66% (3/53) | 3.85 | 0.001193 | 0.017332 |
GO:0033119 | negative regulation of RNA splicing | 3.77% (2/53) | 5.2 | 0.001361 | 0.017529 |
GO:0008482 | sulfite oxidase activity | 1.89% (1/53) | 9.53 | 0.001356 | 0.017641 |
GO:0010477 | response to sulfur dioxide | 1.89% (1/53) | 9.53 | 0.001356 | 0.017641 |
GO:0048539 | bone marrow development | 1.89% (1/53) | 9.53 | 0.001356 | 0.017641 |
GO:0034473 | U1 snRNA 3'-end processing | 1.89% (1/53) | 9.53 | 0.001356 | 0.017641 |
GO:0039534 | negative regulation of MDA-5 signaling pathway | 1.89% (1/53) | 9.53 | 0.001356 | 0.017641 |
GO:1990784 | response to dsDNA | 1.89% (1/53) | 9.53 | 0.001356 | 0.017641 |
GO:1990786 | cellular response to dsDNA | 1.89% (1/53) | 9.53 | 0.001356 | 0.017641 |
GO:0048213 | Golgi vesicle prefusion complex stabilization | 1.89% (1/53) | 9.53 | 0.001356 | 0.017641 |
GO:0034661 | ncRNA catabolic process | 3.77% (2/53) | 5.17 | 0.00143 | 0.018224 |
GO:0016180 | snRNA processing | 3.77% (2/53) | 5.24 | 0.001294 | 0.018371 |
GO:0008380 | RNA splicing | 7.55% (4/53) | 3.01 | 0.001558 | 0.019652 |
GO:0008150 | biological_process | 81.13% (43/53) | 0.4 | 0.00179 | 0.022356 |
GO:0008152 | metabolic process | 60.38% (32/53) | 0.6 | 0.001887 | 0.023108 |
GO:0004532 | exoribonuclease activity | 3.77% (2/53) | 4.97 | 0.001875 | 0.02319 |
GO:0006402 | mRNA catabolic process | 5.66% (3/53) | 3.56 | 0.002149 | 0.025813 |
GO:0003674 | molecular_function | 79.25% (42/53) | 0.41 | 0.002142 | 0.025976 |
GO:0043628 | small regulatory ncRNA 3'-end processing | 3.77% (2/53) | 4.83 | 0.00229 | 0.027244 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 11.32% (6/53) | 2.13 | 0.00244 | 0.028483 |
GO:0008283 | cell population proliferation | 5.66% (3/53) | 3.5 | 0.002419 | 0.0285 |
GO:0140098 | catalytic activity, acting on RNA | 9.43% (5/53) | 2.4 | 0.002564 | 0.029653 |
GO:0062152 | mRNA (cytidine-5-)-methyltransferase activity | 1.89% (1/53) | 8.53 | 0.00271 | 0.030494 |
GO:0004347 | glucose-6-phosphate isomerase activity | 1.89% (1/53) | 8.53 | 0.00271 | 0.030494 |
GO:0043488 | regulation of mRNA stability | 5.66% (3/53) | 3.44 | 0.002708 | 0.031031 |
GO:1901987 | regulation of cell cycle phase transition | 7.55% (4/53) | 2.76 | 0.002881 | 0.032127 |
GO:0016073 | snRNA metabolic process | 3.77% (2/53) | 4.64 | 0.002937 | 0.032468 |
GO:1903313 | positive regulation of mRNA metabolic process | 5.66% (3/53) | 3.36 | 0.00314 | 0.034398 |
GO:0000151 | ubiquitin ligase complex | 7.55% (4/53) | 2.69 | 0.003409 | 0.037026 |
GO:0006401 | RNA catabolic process | 5.66% (3/53) | 3.23 | 0.004075 | 0.039459 |
GO:1990477 | MTREC complex | 1.89% (1/53) | 7.94 | 0.004062 | 0.03964 |
GO:0036415 | regulation of tRNA stability | 1.89% (1/53) | 7.94 | 0.004062 | 0.03964 |
GO:0036416 | tRNA stabilization | 1.89% (1/53) | 7.94 | 0.004062 | 0.03964 |
GO:1902370 | regulation of tRNA catabolic process | 1.89% (1/53) | 7.94 | 0.004062 | 0.03964 |
GO:1902371 | negative regulation of tRNA catabolic process | 1.89% (1/53) | 7.94 | 0.004062 | 0.03964 |
GO:1903326 | regulation of tRNA metabolic process | 1.89% (1/53) | 7.94 | 0.004062 | 0.03964 |
GO:1903327 | negative regulation of tRNA metabolic process | 1.89% (1/53) | 7.94 | 0.004062 | 0.03964 |
GO:0075525 | viral translational termination-reinitiation | 1.89% (1/53) | 7.94 | 0.004062 | 0.03964 |
GO:0039533 | regulation of MDA-5 signaling pathway | 1.89% (1/53) | 7.94 | 0.004062 | 0.03964 |
GO:1904409 | regulation of secretory granule organization | 1.89% (1/53) | 7.94 | 0.004062 | 0.03964 |
GO:1904411 | positive regulation of secretory granule organization | 1.89% (1/53) | 7.94 | 0.004062 | 0.03964 |
GO:0017148 | negative regulation of translation | 5.66% (3/53) | 3.28 | 0.003701 | 0.039852 |
GO:0034249 | negative regulation of cellular amide metabolic process | 5.66% (3/53) | 3.21 | 0.004221 | 0.040558 |
GO:0006913 | nucleocytoplasmic transport | 5.66% (3/53) | 3.2 | 0.004321 | 0.041194 |
GO:0140104 | molecular carrier activity | 3.77% (2/53) | 4.44 | 0.00388 | 0.041425 |
GO:0051169 | nuclear transport | 5.66% (3/53) | 3.19 | 0.004421 | 0.041518 |
GO:0019843 | rRNA binding | 5.66% (3/53) | 3.18 | 0.004472 | 0.041682 |
GO:0031329 | regulation of cellular catabolic process | 9.43% (5/53) | 2.21 | 0.004407 | 0.041696 |
GO:0003727 | single-stranded RNA binding | 5.66% (3/53) | 3.13 | 0.004945 | 0.045414 |
GO:0051252 | regulation of RNA metabolic process | 22.64% (12/53) | 1.19 | 0.004912 | 0.045443 |
GO:0070084 | protein initiator methionine removal | 1.89% (1/53) | 7.53 | 0.005413 | 0.04568 |
GO:0000292 | RNA fragment catabolic process | 1.89% (1/53) | 7.53 | 0.005413 | 0.04568 |
GO:0045694 | regulation of embryo sac egg cell differentiation | 1.89% (1/53) | 7.53 | 0.005413 | 0.04568 |
GO:1903241 | U2-type prespliceosome assembly | 1.89% (1/53) | 7.53 | 0.005413 | 0.04568 |
GO:0002946 | tRNA C5-cytosine methylation | 1.89% (1/53) | 7.53 | 0.005413 | 0.04568 |
GO:0010368 | chloroplast isoamylase complex | 1.89% (1/53) | 7.53 | 0.005413 | 0.04568 |
GO:0030581 | symbiont intracellular protein transport in host | 1.89% (1/53) | 7.53 | 0.005413 | 0.04568 |
GO:0075506 | entry of viral genome into host nucleus through nuclear pore complex via importin | 1.89% (1/53) | 7.53 | 0.005413 | 0.04568 |
GO:0075732 | viral penetration into host nucleus | 1.89% (1/53) | 7.53 | 0.005413 | 0.04568 |
GO:0080034 | host response to induction by symbiont of tumor, nodule or growth in host | 1.89% (1/53) | 7.53 | 0.005413 | 0.04568 |
GO:1900017 | positive regulation of cytokine production involved in inflammatory response | 1.89% (1/53) | 7.53 | 0.005413 | 0.04568 |
GO:0036093 | germ cell proliferation | 1.89% (1/53) | 7.53 | 0.005413 | 0.04568 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 9.43% (5/53) | 2.14 | 0.005493 | 0.04574 |
GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 3.77% (2/53) | 4.19 | 0.005458 | 0.045748 |
GO:0044260 | cellular macromolecule metabolic process | 20.75% (11/53) | 1.24 | 0.005575 | 0.046116 |
GO:0010468 | regulation of gene expression | 26.42% (14/53) | 1.04 | 0.005737 | 0.047146 |
GO:0061629 | RNA polymerase II-specific DNA-binding transcription factor binding | 5.66% (3/53) | 3.05 | 0.005798 | 0.047335 |
GO:0000478 | endonucleolytic cleavage involved in rRNA processing | 3.77% (2/53) | 4.1 | 0.00613 | 0.049717 |